Navigation Links
WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies
Date:12/17/2007

NEW YORK, Dec. 17 /PRNewswire/ -- David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) (http://www.rebuildermedical.com) will be featured in an exclusive interview with http://www.wallst.net scheduled for December 18th. The interview will be posted on http://www.wallst.net by 8 p.m. EST on December 18th.

The interview will cover topics including ReBuilder Medical Technologies, Inc.'s market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed by locating the company's ticker symbol (RBRM) under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window.

About ReBuilder Medical Technologies:

RBRM is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.

More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com and http://www.molluscum.com.

About WallSt.net:

http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Website is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, Financial Filings Corp., a provider of compliance solutions to publicly traded companies, and WallStRadio, a business and finance podcast Website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from ReBuilder Medical Technologies, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.

Contact: WallSt.net

800-4-WALL-ST


'/>"/>
SOURCE Financial Filings Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of Osteologix
2. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
3. WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
4. WallSt.net Announces Upcoming Interview With CEO of Biomoda
5. Synvista Therapeutics to be Featured on Wallst.net
6. WallSt.net Announces Upcoming Interview With CEO Of Immunosyn Corporation
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... ... Creation Technologies, a private company and 25-year leader in ... today announced it has received the ‘Highest Overall Customer Rating’ Service Excellence Award. ... electronics manufacturing services (EMS) providers with annual revenues over $500 million. The award ...
(Date:2/21/2017)... 2017   Logicalis Healthcare Solutions , the healthcare-focused ... managed services provider ( www.us.logicalis.com ), today announced a ... The new service will help hospital CIOs make the ... physicians, nurses and other clinicians immediate access to a ... will allow hospital IT staff to focus on broader ...
(Date:2/21/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 12.8% over the next decade to reach approximately $8.9 ... market estimates and forecasts for all the given segments on global ...
(Date:2/20/2017)... Feb. 20, 2017  This Report analyzes the worldwide markets for ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Latin America ... full report: http://www.reportlinker.com/p04707099-summary/view-report.html ... Annual estimates and forecasts are provided for the ...
Breaking Biology Technology:
(Date:1/30/2017)... SAN FRANCISCO , Jan. 30, 2017   ... of the fastest growing genetic information companies, today announced ... 2016 financial results and provide 2017 guidance on Monday, ... a conference call that day at 4:45 p.m. Eastern ... call, Invitae,s management team will briefly review financial results, ...
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm Reports ... the laboratory use of nuclear magnetic resonance spectroscopy ... end-users and profiled current practices, developments, trends and ... well as growth and opportunities. These areas include ... NMR instruments, needs and innovation requirements, hyphenated NMR ...
Breaking Biology News(10 mins):